A New Paradigm for Primary Prevention Strategy in People with Elevated Risk of Stroke

Abstract

Existing methods of primary stroke prevention are not sufficiently effective. Based on the recently developed Stroke Riskometer app, a new ‘mass-elevated risk stroke/cardiovascular disease prevention’ approach as an addition to the currently adopted absolute risk stroke/cardiovascular disease prevention approach is being advocated. We believe this approach is far more appealing to the individuals concerned and could be as efficient as the conventional population-based approach because it allows identification and engagement in prevention of all individuals who are at an increased (even slightly increased) risk of stroke and cardiovascular disease. The key novelty of this approach is twofold. First, it utilizes modern far-reaching mobile technologies, allowing individuals to calculate their absolute risk of stroke within the next 5 to 10 years and to compare their risk with those of the same age and gender without risk factors. Second, it employs self-management strategies to engage the person concerned in stroke/cardiovascular disease prevention, which is tailored to the person's individual risk profile. Preventative strategies similar to the Stroke Riskometer could be developed for other non-communicable disorders for which reliable predictive models and preventative recommendations exist. This would help reduce the burden of non-communicable disorders worldwide.

Keywords

epidemiology methodology prevention risk factors stroke

Get full access to this article

View all access options for this article.

References

Feigin

Forouzanfar

Krishnamurthi

. Global and regional burden of stroke during 1990–2010: Findings from the Global Burden of Disease Study 2010. Lancet 2014; 383: 245–54.

Feigin

Forouzanfar

Krishnamurthi

. Global and regional burden of stroke in 1990–2010: Findings from the Global Burden of Disease Study 2010. Lancet 2013; 382: 1–12.

Strong

Mathers

Bonita

. Preventing stroke: Saving lives around the world. Lancet Neurol 2007; 6: 182–7.

O'Donnell

Xavier

Liu

. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study. Lancet 2010; 376: 112–23.

Goldstein

Bushnell

Adams

. Guidelines for the primary prevention of stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association.[Erratum appears in Stroke. 2011 Feb;42(2): e26]. Stroke 2011; 42: 517–84.

Mehta

Wells

Riddell

. Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15). J Prim Health Care 2011; 3: 93–101.

Simons

McManus

Dudley

. Discontinuation rates for use of statins are high. BMJ 2000; 321: 1084.

Ebrahim

Taylor

Ward

Beswick

Burke

Smith

Davey G

. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev 2011 (19 April); CD001561.

Cox

Carr

Vallis

Szpilfogel

O'Neill

BJA

. Novel Approach to Cardiovascular Health by Optimizing Risk Management (ANCHOR): A primary prevention initiative examining the impact of health risk factor assessment and management on cardiac wellness. Can J Cardiol 2011; 27: 809–17.

10.

Selak

Elley

Crengle

. IMProving Adherence using Combination Therapy (IMPACT): Design and protocol of a randomised controlled trial in primary care. Contemp Clin Trials 2011; 32: 909–15.

11.

Jackson

Lawes

CMM

Bennett

Milne

Rodgers

. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 2005; 365: 434–41.

12.

Powers

Danus

Grubber

Olsen

Oddone

Bosworth

. The effectiveness of personalized coronary heart disease and stroke risk communication. Am Heart J 2011; 161: 673–80.

13.

Feigin

Krishnamurthi

. Stroke prevention in the developing world. Stroke 2011; 42: 3655–8.

14.

Rose

. Strategy of prevention: Lessons from cardiovascular disease. Br Med J (Clin Res Ed) 1981; 282: 1847–51.

15.

Reid

Hamilton

McCartney

Rose

Jarrett

Keen

. Smoking and other risk factors for coronary heart-disease in British civil servants. Lancet 1976; 2: 979–84.

16.

WHO. Prevention of cardiovascular disease: Pocket guidelines for assessment and management of cardiovascular risk. Geneva, 2007.

17.

D'Agostino

Wolf

Belanger

Kannel

. Stroke risk profile: Adjustment for antihypertensive medication. The Framingham Study. Stroke 1994; 25: 40–3.

18.

Riddell

Wells

Jackson

. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10. N Z Med J 2010; 123: 50–61.

19.

Feigin

. Stroke Riskometer App. 2013. Available at http://www.nisan.aut.ac.nz/stroke-riskometer (accessed 14 May 2014).

20.

National Vascular Prevention Alliance. Guidelines for the Management of Absolute Cardiovascular Disease Risk. Canberra, National Health and Medical Research Council of Australia, 2012.

21.

New Zealand Guidelines Group. New Zealand Cardiovascular Guidelines Handbook: A Summary Resource for Primary Care Practitioners, 2nd edn. Ministry of Health, Wellington, 2009.

22.

Goris

Komaric

Guandalini

Francis

Hawes

. Effectiveness of multicultural health workers in chronic disease prevention and selfmanagement in culturally and linguistically diverse populations: A systematic literature review. Aus J Prim Health 2013; 19: 14–37.

23.

Kulzer

Hermanns

Gorges

Schwarz

Haak

. Prevention of diabetes self-management program (PREDIAS): Effects on weight, metabolic risk factors, and behavioral outcomes. Diabetes Care 2009; 32: 1143–6.